(Q48182822)

9 February 2018

title

The neuroendocrine effects of sumatriptan, a specific ligand for 5-HT1-like receptors (English)

1 reference

9 February 2018

author

Fabio Facchinetti

1

1 reference

9 February 2018

Giuseppe Nappi

5

object named as

Nappi G

1 reference

9 February 2018

Nappi RE

2

1 reference

9 February 2018

Sances G

3

1 reference

9 February 2018

Fioroni L

4

1 reference

9 February 2018

Genazzani AR

6

1 reference

9 February 2018

publication date

1 February 1994

1 reference

9 February 2018

published in

Clinical Endocrinology

1 reference

9 February 2018

volume

40

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

211-214

1 reference

9 February 2018

The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02470.X

Effects of L-5HTP with and without carbidopa on plasma beta-endorphin and pain perception: possible implications in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02470.X

Anti-migraine drugs in development: advances in serotonin receptor pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02470.X

Stimulation of beta-endorphin and beta-lipotropin release from the anterior but not the neurointermediate pituitary lobe in the rat after acute administration of serotonin-acting drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02470.X

Endocrine effects of sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1994.TB02470.X

10.1111/J.1365-2265.1994.TB02470.X

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018